Research Article
[Retracted] Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
Table 1
Clinical and histopathological characteristics of 65 extrahepatic cholangiocarcinoma.
| | No. of patients (%) | |
| | Gender (%) | | | Male | 37 (56.9) | | Female | 28 (43.1) | | Age (%) | | | ≥65 years | 22 (33.8) | | <65 years | 43 (66.2) | | Tumour size (%) | | | >2.5 cm | 35 (53.8) | | ≤2.5 cm | 30 (46.2) | | Pathologic differentiation (%) | | | Well | 30 (46.2) | | Moderate | 29 (44.6) | | Poor | 6 (9.2) | | Lymphatic permeation (%) | | | No | 32 (49.2) | | Yes | 33 (50.8) | | Tumor stage (%) | | | I+II | 25 (38.5) | | III+IV | 40 (61.5) | | 14-3-3δlevel (%) | | | Negative | 12 (18.5) | | Positive | 53 (81.5) |
|
|